BIOLIFE SOLUTIONS INC 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001628280-26-032148
- Form type
- 10-Q
- CIK
- 0000834365
- Primary document
- https://www.sec.gov/Archives/edgar/data/834365/000162828026032148/blfs-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOLIFE SOLUTIONS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Cost Of Revenue | $10.0M | - | - |
| Gross Profit | $17.5M | - | - |
| Operating Income | $27,000 | - | - |
| Net Income | $1.2M | - | - |
| Eps Basic | 0.02 | - | - |
| Eps Diluted | 0.02 | - | - |
| Cash And Equivalents | $22.8M | - | - |
| Total Assets | $400.9M | - | - |
| Total Liabilities | $28.7M | - | - |
| Shareholders Equity | $372.2M | - | - |
| Operating Cash Flow | $-491,000 | - | - |
| Capital Expenditures | $167,000 | - | - |